申请人:Borza Istvan
公开号:US20080300276A1
公开(公告)日:2008-12-04
The invention relates to new heterocyclic carboxylic acid amide derivatives of formula (I)—wherein the meaning of X is hydrogen or halogen atom, hydroxy, cyano, C
1
-C
4
alkylsulfonamido optionally substituted by a halogen atom or halogen atoms, C
1
-C
4
alkanoylamido optionally substituted by a halogen atom or halogen atoms, arylsulfonamido groups, is —CH═ group or —N═ atom, Z is one or more hydrogen or halogen atom, C
1
-C
4
alkyl, C
1
-C
4
alkoxy, cyano, trifluromethyl, trifluoromethoxy group and to the salts thereof, which are antagonists of NMDA receptor or are intermediates for preparing thereof.
本发明涉及一种新的杂环羧酸酰胺衍生物,其化学式为(I),其中X的含义为氢原子或卤素原子、羟基、氰基、C1-C4烷基磺酰胺基(可选地被卤素原子或卤素原子取代)、C1-C4酰胺基(可选地被卤素原子或卤素原子取代)、芳基磺酰胺基、-CH═基或-N═原子,Z为一个或多个氢原子或卤素原子、C1-C4烷基、C1-C4烷氧基、氰基、三氟甲基、三氟甲氧基,以及其盐,它们是NMDA受体拮抗剂或其制备的中间体。